08:30 AM EDT, 08/26/2025 (MT Newswires) -- Bausch Health Companies ( BHC ) said Tuesday its subsidiary has extended the expiration date of its tender offer to acquire all of the outstanding shares of DURECT Corporation ( DRRX ) till Sept. 10 from the earlier deadline of Sept. 9.

Bausch Health ( BHC ), during July, had announced to acquire DURECT ( DRRX ) for $1.75 per share in an all-cash transaction for an upfront consideration of approximately $63 million.

The company had said that this transaction bakes in with the potential for two additional net sales milestone payments of up to $350 million in the aggregate if the milestones are achieved before the earlier of the 10-year anniversary of the first commercial sale of larsucosterol in the US and December 31, 2045.